Clomid vs Nolvadex for PCT: How They Differ and How They Stack
Last updated: April 2026. Written by the Elite Bio Supply research team. Every product is sourced from verified pharmaceutical manufacturers, blister packed with batch identification, and inspected before dispatch.
Clomid (clomiphene citrate) and Nolvadex (tamoxifen citrate) are the two most cited SERMs in post cycle therapy protocols. They are not interchangeable. They act at different tissues, have different side effect profiles, and serve different roles in a stack. Most published bodybuilding PCT protocols run them together. The questions that drive the “clomid vs nolvadex pct” search are: how do they differ mechanistically, what are the standard dosages, can you run one without the other, and which side effect profile fits a given researcher. This page covers all of that and ends with how EBS fits into the stack.
Elite Bio Supply sells clomiphene citrate (100 mg, 30 tablets) as a research compound. Tamoxifen citrate is on our product roadmap but is not currently in stock. The honest framing of this page: the science is the science, the protocols are the protocols, and we will tell you up front that EBS supplies one half of the standard PCT stack today.
Quick answer (if you only read one paragraph)
Clomid and Nolvadex are both selective estrogen receptor modulators (SERMs), but they do different jobs. Clomid acts primarily at the hypothalamus, where it blocks estrogen feedback and drives the LH and FSH surge that restarts natural testosterone production. Nolvadex acts primarily at breast tissue, where it blocks estrogen receptors directly and prevents gynecomastia, with secondary support of the HPTA. The standard PCT stack is Clomid 50 mg daily plus Nolvadex 20 mg daily for the first two weeks, dropping to Clomid 25 mg plus Nolvadex 20 mg for weeks three and four. Clomid alone restarts the axis but leaves chest tissue exposed to estrogen rebound. Nolvadex alone protects the chest but provides weaker HPTA recovery. Most protocols run both because they cover different failure modes.
Table of contents
- What is Clomid (clomiphene citrate)
- What is Nolvadex (tamoxifen citrate)
- Mechanism of action: where they differ
- Side by side comparison
- Standard PCT dosage and protocol
- Clomid alone vs Nolvadex alone vs both
- Side effects: how they differ
- What researchers are actually running
- The isomer question: enclomiphene as a third option
- Where EBS fits in the stack
- FAQ
What is Clomid (clomiphene citrate)
Clomid is the brand name for clomiphene citrate, a SERM first approved in 1967 for female infertility. Structurally, it is a triphenylethylene derivative composed of two isomers: enclomiphene (the trans isomer, a pure estrogen antagonist at the hypothalamus) and zuclomiphene (the cis isomer, a weak estrogen agonist with a long half life of approximately 30 days). The active isomer for HPTA recovery is enclomiphene. Zuclomiphene is responsible for most of the reported mood and vision side effects.
The PCT use case rests on the hypothalamic action: blocking estrogen feedback there causes the hypothalamus to ramp GnRH output back up, which drives LH and FSH release from the pituitary, which tells the testes to resume testosterone production. Clomid is the most cited compound for this restart effect because the literature on it is the deepest, going back six decades.
What is Nolvadex (tamoxifen citrate)
Nolvadex is the brand name for tamoxifen citrate, a SERM first approved in the 1970s primarily for breast cancer treatment. Like clomiphene, it is a triphenylethylene derivative that acts as a tissue selective estrogen receptor modulator. The clinical use case in oncology is the antagonist effect at breast tissue, which makes it the foundational treatment for estrogen receptor positive breast cancer.
In a PCT context, the breast tissue antagonism is what protects against gynecomastia rebound. Tamoxifen also has secondary action at the hypothalamus, where it produces a milder version of the LH and FSH increase that clomiphene drives. The half life is approximately 5 to 7 days, similar to enclomiphene and considerably shorter than zuclomiphene’s 30 day persistence.
Mechanism of action: where they differ
Both are SERMs. Both block estrogen receptors at some sites and activate them at others. The clinically meaningful difference is the tissue selectivity profile.
Clomid (clomiphene citrate):
– Strong antagonist at the hypothalamus (blocks estrogen feedback, drives GnRH and LH release)
– Mild agonist at the liver (mild lipid effects, generally neutral to slightly positive)
– Weaker antagonist at breast tissue compared to tamoxifen
Nolvadex (tamoxifen citrate):
– Strong antagonist at breast tissue (blocks estrogen receptors there, prevents gynecomastia)
– Moderate antagonist at the hypothalamus (mild HPTA support, weaker than clomiphene)
– Mild agonist at the liver and bone (positive bone density effect, can lower IGF 1)
The practical translation: Clomid is the recovery driver, Nolvadex is the gyno guard, and they cover different failure modes that can both happen during a PCT.
Side by side comparison
| Feature | Clomid (clomiphene citrate) | Nolvadex (tamoxifen citrate) |
|---|---|---|
| Drug class | SERM (triphenylethylene) | SERM (triphenylethylene) |
| Primary clinical use | Female infertility | Breast cancer (ER positive) |
| Half life | Enclomiphene 5 to 7 days, zuclomiphene approximately 30 days | 5 to 7 days |
| Site of primary action | Hypothalamus | Breast tissue |
| Site of secondary action | Mild liver agonism | Hypothalamus (moderate) |
| PCT role | Restart HPTA, drive LH and FSH | Block gyno, mild HPTA support |
| Standard PCT dose | 25 to 50 mg daily | 20 to 40 mg daily |
| Typical 4 week protocol | 50 mg week 1 to 2, 25 mg week 3 to 4 | 20 mg daily for 4 weeks |
| Mood side effects | Moderate to high (zuclomiphene) | Low to moderate |
| Vision side effects | Possible at high dose (zuclomiphene) | Very rare |
| Lipid effects | Neutral to mildly positive | Mildly positive on lipids, can lower IGF 1 |
| Gyno protection | Weak | Strong |
| HPTA recovery effect | Strong | Moderate |
Standard PCT dosage and protocol
The classic 4 week stack reported in published bodybuilding PCT protocols:
| Week | Clomid | Nolvadex |
|---|---|---|
| Week 1 | 50 mg daily | 20 mg daily |
| Week 2 | 50 mg daily | 20 mg daily |
| Week 3 | 25 mg daily | 20 mg daily |
| Week 4 | 25 mg daily | 20 mg daily |
For heavier cycles, some researchers frontload Clomid at 100 mg daily for the first 3 to 7 days, then drop to 50 mg. Nolvadex is rarely frontloaded because the standard 20 mg dose already saturates the relevant receptors. For lighter cycles or maintenance protocols, some researchers cut Clomid to 25 mg daily throughout and keep Nolvadex at 10 to 20 mg.
Timing in published protocols depends on the ester half life of the androgen used. For short esters (testosterone propionate, trenbolone acetate), the protocol begins 3 to 4 days after last administration. For long esters (testosterone enanthate, cypionate), the reported clearance window is 14 to 18 days. For nandrolone decanoate, the literature recommends 3 weeks or more.
Full week by week dosing tables are on the Clomid PCT protocol page.
Clomid alone vs Nolvadex alone vs both
The three valid combinations and what each one trades off.
Both (Clomid plus Nolvadex): the standard. Covers both failure modes (HPTA shutdown and gyno rebound). Highest combined side effect load but most complete protocol. Recommended in published protocols for moderate to heavy cycles.
Clomid alone: drives the HPTA restart, leaves breast tissue exposed to estrogen rebound during the recovery window. Workable for cycles with low aromatization risk (mild orals, very short cycles, low total dose) but generally not recommended where any meaningful aromatization occurred. Mood and vision side effect risk is on the high side because the full clomiphene dose is doing the work alone.
Nolvadex alone: protects breast tissue, provides weaker HPTA recovery support. Workable for very mild cycles where HPTA suppression is minimal (short SARM only protocols, very low dose orals) but generally insufficient for moderate or heavy cycles. The recovery curve is slower than with clomiphene.
The honest read: both is the default. One alone is a choice researchers make when the cycle was light enough that the full stack would be overkill, or when the side effect profile of one of the two compounds is incompatible with the researcher (vision sensitivity to clomiphene, for example).
Side effects: how they differ
Both compounds are well tolerated by most users at PCT doses, but the profiles are different.
Clomid (clomiphene citrate):
– Mood shifts, irritability, emotional blunting (driven mostly by zuclomiphene)
– Reduced libido during the protocol (temporary; resolves as testosterone recovers)
– Visual disturbances at high dose: blurring, floaters, light sensitivity. Stop the compound if this happens.
– Headache, hot flashes
– Mild liver enzyme elevation in extended protocols
Nolvadex (tamoxifen citrate):
– Hot flashes
– Reduced libido during the protocol
– Mild nausea or GI discomfort in some users
– IGF 1 reduction (matters for researchers running growth hormone secretagogues alongside PCT)
– Rare risk of thromboembolic events at high or extended doses
– Vision disturbances are rare
The mood and vision side effects on Clomid are the main reason researchers sometimes switch to enclomiphene monotherapy or run Nolvadex alone for sensitive cases. The IGF 1 reduction on Nolvadex is the main reason it gets paired with rather than replaced by Clomid in protocols where growth hormone is also a consideration.
Full side effect review including long term clomiphene monotherapy data is on the Clomid PCT side effects page.
What researchers are actually running
The pattern across r/steroids, r/PEDs, and the major Canadian research forums is consistent.
The default stack: “Standard 4 week PCT, Clomid 50/50/25/25, Nolva 20 across the board, started X days post last pin.” This is the most common protocol described in current threads. It maps to the published literature and works for moderate cycles.
The enclomiphene shift: “I dropped Clomid for enclomiphene because the mood side effects were brutal, kept Nolva.” The shift to pure enclomiphene plus tamoxifen is common among researchers sensitive to zuclomiphene. The HPTA recovery effect is similar; the side effect load is lower.
Nolvadex only on light cycles: “Just ran a 4 week SARM cycle, Nolva 20 mg for 3 weeks, recovery was fine.” This works for cycles with minimal HPTA suppression. It does not work for moderate or heavy cycles.
Clomid only: Less commonly reported. Researchers who skip Nolvadex entirely tend to do so for cost or supply reasons, not protocol reasons, and gyno rebound is the failure mode that gets reported when the cycle had any meaningful aromatization.
The isomer question: enclomiphene as a third option
Clomiphene citrate is 62 percent enclomiphene and 38 percent zuclomiphene. Enclomiphene is the active isomer for HPTA recovery. Zuclomiphene causes most of the mood and vision side effects.
Pure enclomiphene at 12.5 to 25 mg daily has been reported to produce LH and FSH increases comparable to clomiphene at 50 mg daily, without the zuclomiphene overhang (Wiehle 2013, Earl 2019). This is why many researchers have moved from clomiphene to enclomiphene for the HPTA recovery slot, while keeping tamoxifen in the breast tissue protection slot.
The stack becomes: enclomiphene 12.5 to 25 mg daily plus tamoxifen 20 mg daily for the recovery period. Same coverage of both failure modes, lower side effect load.
See enclomiphene vs clomid for the full comparison.
Where EBS fits in the stack
Honest scope: Elite Bio Supply sells clomiphene citrate (100 mg, 30 tablets) and enclomiphene citrate (50 mg, 5 tablets) for the HPTA recovery slot. Tamoxifen citrate is on our roadmap but is not currently in stock.
What this means for a researcher building a PCT stack:
- Clomid plus Nolvadex (standard stack): EBS supplies the Clomid side. Tamoxifen needs to come from another supplier in the meantime.
- Enclomiphene plus Nolvadex (lower side effect stack): EBS supplies the enclomiphene side. Tamoxifen needs to come from another supplier in the meantime.
- Clomid alone or enclomiphene alone: EBS supplies the full stack.
Why no tamoxifen yet: we are running our catalogue expansion deliberately. Each new SKU goes through a sourcing audit, batch testing setup, and lot tracking integration before it goes live. Tamoxifen is a high priority addition for 2026 but we will not list it until the testing and lot tracking are in place at the same standard as our current SKUs.
What EBS does on the SKUs we ship today:
– Verified pharmaceutical sourcing. Sealed, labelled products from verified pharmaceutical manufacturers. Blister packed with batch identification. Every order inspected before dispatch.
– Canadian owned and shipped. Canada Post domestic, 2 to 5 business days. No CBSA exposure.
– CAD pricing. $50 CAD on sale for clomiphene 100 mg. No FX surprise at checkout.
– Reship on seizure. If Canada Post returns or detains a package due to inspection, we reship once at no cost.
– Interac e Transfer and crypto. Bank to bank Canadian payment plus BTC, ETH, USDT, and over 350 cryptocurrencies through NOWPayments.
FAQ
Should I run Clomid and Nolvadex together for PCT?
The published standard for moderate to heavy cycles is to run both. Clomid drives HPTA recovery, Nolvadex protects breast tissue. They cover different failure modes and the combination is the default protocol.
Can I run Clomid without Nolvadex?
Workable for cycles with low aromatization risk (mild orals, very short cycles). Not recommended where any meaningful aromatization occurred, because the breast tissue is exposed to estrogen rebound during the recovery window.
Can I run Nolvadex without Clomid?
Workable for very mild cycles where HPTA suppression is minimal (short SARM only protocols, very low dose orals). Not sufficient for moderate or heavy cycles, because the HPTA recovery effect is weaker than what clomiphene drives.
What is the standard Clomid and Nolvadex PCT dosage?
Clomid 50 mg daily plus Nolvadex 20 mg daily for the first two weeks, dropping to Clomid 25 mg plus Nolvadex 20 mg for weeks three and four. Frontloading 100 mg Clomid for the first 3 to 7 days is common for heavier cycles.
Is Nolvadex better than Clomid for PCT?
Neither is “better” in isolation. They do different jobs. Clomid drives HPTA recovery. Nolvadex blocks gyno. Most protocols run both.
What are the side effects of Clomid vs Nolvadex?
Clomid: mood shifts, possible vision disturbances at high dose, hot flashes. Nolvadex: hot flashes, reduced libido, lower IGF 1, rare thromboembolic risk at extended dosing. Vision side effects are rare on Nolvadex.
Why do researchers switch from Clomid to enclomiphene?
Clomiphene is 62 percent enclomiphene plus 38 percent zuclomiphene. The mood and vision side effects come mostly from zuclomiphene. Pure enclomiphene gives the same HPTA recovery effect with a cleaner side effect profile.
Does EBS sell tamoxifen?
Not currently. Tamoxifen citrate is on our roadmap but is not in stock. We will not list it until our batch testing and lot tracking standard is set up at the same level as our current SKUs.
Where can I buy clomiphene citrate in Canada?
EBS ships clomiphene citrate 100 mg, 30 tablets domestically across Canada. $50 CAD on sale. Sealed and labelled from a verified pharmaceutical manufacturer with batch identification. Canada Post 2 to 5 day shipping with seizure reship.
How long should a Clomid and Nolvadex PCT last?
Standard is 4 weeks. Heavy or long cycles may run 6 weeks. Anything beyond 6 weeks has diminishing returns and rising side effect risk.
References
1. Moskovic DJ, Katz DJ, Akhavan A, et al. (2012). “Clomiphene citrate is safe and effective for long term management of hypogonadism.” *BJU International*. PMID: 22458540.
2. Ramasamy R, Scovell JM, Kovac JR, Lipshultz LI. (2014). “Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.” *Journal of Urology*. PMID: 24657837.
3. Wiehle RD, Fontenot GK, Wike J, et al. (2013). “Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial.” *Fertility and Sterility*. DOI: 10.1016/j.fertnstert.2013.02.040.
4. Wiehle RD, Cunningham GR, Pitteloud N, et al. (2014). “Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics.” *Fertility and Sterility*. PMID: 25044085.
5. Earl JA, Kim ED. (2019). “Enclomiphene citrate: a treatment that maintains fertility in men with secondary hypogonadism.” *Expert Review of Endocrinology and Metabolism*. PMID: 31063005.
6. Katz DJ, Nabulsi O, Tal R, Mulhall JP. (2012). “Outcomes of clomiphene citrate treatment in young hypogonadal men.” *BJU International*. PMID: 22044663.
Research compound disclaimer
The compounds referenced on this page are sold by Elite Bio Supply as research compounds intended for in vitro and laboratory research use only. They are not for human or veterinary consumption, not pharmaceuticals, not dietary supplements, and have no DIN. Tamoxifen citrate is referenced in this guide for educational comparison and is not currently part of the EBS catalogue. Nothing on this page constitutes medical advice. Always consult a qualified healthcare provider about medical decisions.